Analogues of N-hydroxy-4-acetylaminobiphenyl as substrates and inactivators of hamster hepatic acetyltransferases

References

• Andersen R. A., Enomoto M., Miller E. C., Miller J. A. Carcinogenesis and inhibition of the Walker 256 tumor in the rat by trans-4-acetylaminostilbene, its N-hydroxy metabolite, and related compounds. Cancer Research 1964; 24: 128–143
   PubMed Web of Science ®Google Scholar
• Banks R. B., Hanna P. E. Arylhydroxamic acid N,O-acyltransferase. Apparent suicide inactivation by carcinogenic N-arylhydroxamic acids. Biochemical and Biophysical Research Communications 1979; 4: 1423–1429
   Google Scholar
• Banks R. B., Smith T. J., Hanna P. E. N-Arylhydroxamic acid N,O-acyltransferase. Positional requirements for the substrate hydroxyl group. Journal of Medicinal Chemistry 1983; 26: 1780–1784
   Google Scholar
• Bartsch H., Dworkin M., Miller J. A., Miller E. C. Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. Biochimica et Biophysica Acta 1972; 286: 272–298
   PubMed Web of Science ®Google Scholar
• Booth J. Acetyl transfer in arylamine metabolism. Biochemical Journal 1966; 100: 745–753
   Google Scholar
• Draper W. M., Casida J. E. Diphenyl ether herbicides and related compounds: structure-activity relationships as bacterial mutagens. Journal of Agricultural and Food Chemistry 1983; 31: 1201–1207
   PubMed Web of Science ®Google Scholar
• Elfarra A. A., Hanna P. E. Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase. Journal of Medicinal Chemistry 1985; 28: 1453–1460
   PubMedGoogle Scholar
• Elfarra A. A., Yeh H. M., Hanna P. E. Synthesis and evluation of N-(phenylalkyl)acetohydroxamic acids as potential substrates for N-arylhydroxamic acid N,O-acyltransferase. Journal of Medicinal Chemistry 1982; 25: 1189–1192
   Google Scholar
• Franz R., Neumann H. G. Reaction of trans-4-N-acetoxy-N-acetylaminostilbene with guanosine and deoxyguanosine in vitro: the primary reaction product at N2 of guanine yields different final adducts. Chemico-Biological Interactions 1988; 67: 105–116
   Google Scholar
• Gammans R. E., Sehon R. D., Anders M. W., Hanna P. E. Microsomal N-hydroxylation of trans-4′-halo-4-acetamidostilbenes. Drug Metabolism and Disposition 1977; 5: 310–316
   PubMed Web of Science ®Google Scholar
• Garner R. C., Martin C. N., Clayson D. B. Carcinogenic aromatic amines and related compounds. Chemical Carcinogens 2nd edn., C. E. Searle. American Chemical Society, Washington, DC 1984; Vol. I: 175–276
   Google Scholar
• Glowinski I. B., Weber W. W., Fysh J. M., Vaught J. B., King C. M. Evidence that arylhydroxamic acid N,O-acyltransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rat liver. Journal of Biological Chemistry 1980; 255: 7883–7890
   PubMed Web of Science ®Google Scholar
• Groutas W. C., Brubaker M. J., Stanya M. A., Castrisos J. C., Crowley J. P., Schatz E. J. Inhibition of human leukocyte clastase by derivatives of N-hydroxysuccinimide. A structure-activity relationship study. Journal of Medicinal Chemistry 1989; 32: 1607–1611
   PubMed Web of Science ®Google Scholar
• Hanna P. E., Banks R. B., Marhevka V. C. Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity. Molecular Pharmacology 1982; 21: 159–165
   PubMed Web of Science ®Google Scholar
• Hanna P. E., Banks R. B. Arylhydroxylamines and arylhydroxamic acids: conjugation reactions. Bioactivation of Foreign Compounds, M. W. Anders. Academic Press, New York 1985; 376–402
   Google Scholar
• Hansch C., Leo A. J. Substituent Constants for Correlation Analysis in Chemistry and Biology. John Wiley and Sons, New York 1979, Appendix 1
   Google Scholar
• Hein D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochemica et Biophysica Acta 1988; 948: 37–66
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Beland F. A. Chemical properties of ultimate carcinogenic metabolites of arylamines and arylamides,. Polycyclic Hydrocarbons and Carcinogenesis, R. G. Harvey. American Chemical Society, Washington, DC 1985; 341–370
   Google Scholar
• King C. M. Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase. Cancer Research 1974; 34: 1503–1515
   PubMed Web of Science ®Google Scholar
• King C. M., Glowinski I. B. Acetylation, deacetylation and acyltransfer. Environmental Health Perspectives 1983; 49: 43–50
   PubMed Web of Science ®Google Scholar
• Kitz R., Wilson I. B. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. Journal of Biological Chemistry 1962; 237: 3245–3249
   PubMed Web of Science ®Google Scholar
• Kumano T., Yoshioka T., Umeatsu T. Comparative effects of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalysed transacylation. Drug Metabolism and Disposition 1986; 14: 487–493
   Google Scholar
• Lotlikar P. D. Nitrogenous carcinogenic industrial chemicals,. Carcinogens in Industry and the Environment, J. M. Sontag. Marcel Dekker, New York 1981; 345–437
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Malejka-Giganti D. Carcinogenicity of N-arylhydroxamic acids: a review of structure-activity relationship. Chemistry ahnd Biology of Hydroxamic Acids, H. Kehl. S. Karger, New York 1982; 149–159
   Google Scholar
• Mangold B. L. K., Hanna P. E. Arylhydroxamic acid N,O-acyltransferase substrates. Acetyl transfer and electrophile generating activity of N-hydroxy-N-(4-alkyl, 4-alkenyl, and 4-cyclohexylphenyl)acetamides. Journal of Medicinal Chemistry 1982; 25: 630–638
   PubMedGoogle Scholar
• Marhevka V. C., Ebner N. A., Sehon R. D., Hanna P. E. Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes. Journal of Medicinal Chemistry 1985; 28: 18–24
   Google Scholar
• Mattano S. S., Land S., King C. M., Weber W. W. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase. Molecular Pharmacology 1989; 35: 599–609
   Google Scholar
• Miller E. C., Miller J. A. Some historical perspectives on the metabolism of xenobiotic chemicals to reactive electrophiles,. Bioactivation of Foreign Compounds, M. W. Anders. Academic Press, New York 1985; 3–28
   Google Scholar
• Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981; 47: 2327–2345
   PubMed Web of Science ®Google Scholar
• Moller L., Rafter J., Gustafsson J. A. Metabolism of the carcinogenic air pollutant 2-nitrofluorene in the rat. Carcinogenesis 1987; 8: 637–645
   PubMed Web of Science ®Google Scholar
• Powers J. C. Haloketone inhibitors of proteolytic enzymes,. Chemistry and Biochemistry of Amino Acids, Peptides and Proteins, B. Weinstein. Marcel Dekker, New York 1977; Vol. 4: 78–81
   Google Scholar
• Saito K., Shinohara A., Kamataki T., Kato R. N-hydroxyarylamine O-acetyltransferase in hamster liver: identity with arylhydroxamic acid N,O-acetyltransferase. Journal of Biochemistry (Tokyo) 1986; 99: 1689–1697
   PubMed Web of Science ®Google Scholar
• Smith T. J., Hanna P. E. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes. Carcinogenesis 1986; 7: 697–702
   PubMed Web of Science ®Google Scholar
• Smith T. J., Hanna P. E. Hepatic N-acetyltransferases: selective inactivation in vivo by a carcinogenic N-arylhydroxamic acid. Biochemical Pharmacology 1988; 37: 427–434
   PubMed Web of Science ®Google Scholar
• Szmant H. H. The sulfur-oxygen bond,. Sulfur in Organic and Inorganic Chemistry, A. Stenning. Marcel Dekker, New York 1971; Vol. 1: 136–138
   Google Scholar
• Weber W. W., Hein D. W. N-Acetylation pharmacogenetics. Pharmacological Reviews 1985; 37: 25–79
   PubMed Web of Science ®Google Scholar
• Wick M. J., Hanna P. E. Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase: detection of multiple enzyme forms by mechanism-based inactivation. Biochemical Pharmacology 1990; 39: 991–1003
   Google Scholar
• Wick M. J., Jantan I. B., Hanna P. E. Irreversible inhibition of rat hepatic transacetylase activity by N-arylhydroxamic acids. Biochemical Pharmacology 1988; 37: 1225–1231
   Google Scholar
• Yeh H. M., Hanna P. E. Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds. Journal of Medicinal Chemistry 1982; 25: 842–846
   Google Scholar
• Yoshimura T., Barker L. N., Powers J. C. Specificity and reactivity of human leukocyte elastase, porcine pancreatic elastase, human granulocyte cathepsin G, and bovine pancreatic chymotrypsin with arylsulfonyl fluorides. Journal of Biological Chemistry 1982; 257: 5077–5084
   Google Scholar